These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38242493)
1. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment. Yadav G; Kulshreshtha R Life Sci; 2024 Feb; 339():122438. PubMed ID: 38242493 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
3. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis. Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers. Gao X; Bu H; Gao X; Wang Y; Wang L; Zhang Z FASEB J; 2023 Oct; 37(10):e23159. PubMed ID: 37650687 [TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer. Du Y; Wei N; Ma R; Jiang SH; Song D Front Oncol; 2020; 10():580176. PubMed ID: 33392077 [TBL] [Abstract][Full Text] [Related]
7. Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer. Ruan Z; Xu Z; Li Z; Lv Y Oncol Lett; 2019 Aug; 18(2):1107-1116. PubMed ID: 31423171 [TBL] [Abstract][Full Text] [Related]
8. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis. Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545 [TBL] [Abstract][Full Text] [Related]
9. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis. Wang Y; Gong H; Cao Y Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547 [TBL] [Abstract][Full Text] [Related]
10. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data. Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374 [TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X Front Immunol; 2023; 14():1071675. PubMed ID: 36761737 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration. Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913 [TBL] [Abstract][Full Text] [Related]
13. Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis. Shenoy US; Basavarajappa DS; Kabekkodu SP; Radhakrishnan R Clin Exp Med; 2024 Jun; 24(1):134. PubMed ID: 38904676 [TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of the DNA methylation patterns of long non-coding RNA. Wang S; Wang R; Gao F; Huang J; Zhao X; Li D Genomics; 2022 Jul; 114(4):110377. PubMed ID: 35513292 [TBL] [Abstract][Full Text] [Related]
15. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma. Wang Y; Li W; Chen X; Li Y; Wen P; Xu F Biomed Pharmacother; 2019 Mar; 111():1297-1301. PubMed ID: 30841443 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer. Liu P; Huang H; Qi X; Bian C; Cheng M; Liu L; Xue L; Zhao X; Yi T; Quan Y Front Oncol; 2021; 11():701488. PubMed ID: 34900667 [TBL] [Abstract][Full Text] [Related]
17. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers. Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455 [TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B PeerJ; 2022; 10():e14432. PubMed ID: 36518297 [TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker. Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933 [TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis based on epigenetic modification explains the value of HJURP in the tumor microenvironment. Li J; Zheng J; Zhang R; Zhang W; Zhang J; Zhang Y Sci Rep; 2022 Dec; 12(1):20871. PubMed ID: 36460821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]